Tower Research Capital (TRC)’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,049
| Closed | -$9.27K | – | 6274 |
|
2023
Q4 | $9.27K | Sell |
3,049
-3,868
| -56% | -$11.8K | ﹤0.01% | 4412 |
|
2023
Q3 | $19.6K | Buy |
6,917
+5,211
| +305% | +$14.8K | ﹤0.01% | 3393 |
|
2023
Q2 | $4.44K | Buy |
+1,706
| New | +$4.44K | ﹤0.01% | 4923 |
|
2022
Q4 | – | Sell |
-5,859
| Closed | -$11K | – | 6569 |
|
2022
Q3 | $11K | Sell |
5,859
-141
| -2% | -$265 | ﹤0.01% | 4486 |
|
2022
Q2 | $18K | Buy |
6,000
+1,442
| +32% | +$4.33K | ﹤0.01% | 3928 |
|
2022
Q1 | $17K | Buy |
4,558
+2,380
| +109% | +$8.88K | ﹤0.01% | 3724 |
|
2021
Q4 | $25K | Buy |
2,178
+1,781
| +449% | +$20.4K | ﹤0.01% | 3449 |
|
2021
Q3 | $7K | Buy |
+397
| New | +$7K | ﹤0.01% | 4698 |
|